MOBILE, Ala. / Jun 10, 2025 / Business Wire / TruBridge, Inc. (NASDAQ:TBRG), a healthcare technology and services company, today announced that management will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference, to be held in New York on June 24-25, 2025.
The panel discussion on “Optimizing Healthcare Workflows” with Chris Fowler, president and chief executive officer, will begin at approximately 3:30 p.m. Eastern Time on Wednesday, June 25, 2025.
About TruBridge
We partner with over 1,500 healthcare organizations to deliver technology-first solutions that improve access, outcomes, and operational efficiency. Backed by more than 45 years of experience, our HFMA Peer Reviewed® revenue cycle management (RCM) suite enhances transparency, productivity, and financial health across care settings. From electronic health record (EHR) integration across care settings to value-based care support, our data-driven tools connect providers, patients, and communities—driving better care and patient satisfaction. At our core, we believe in the power of community, collaboration and creating lasting value for our customers. We clear the way for care. For more information, please visit www.trubridge.com.
| Last Trade: | US$19.87 |
| Daily Change: | -0.03 -0.15 |
| Daily Volume: | 19,468 |
| Market Cap: | US$298.250M |
October 03, 2025 September 23, 2025 August 07, 2025 May 07, 2025 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
